366 related articles for article (PubMed ID: 33334367)
1. Long noncoding RNA MIR31HG and its splice variants regulate proliferation and migration: prognostic implications for muscle invasive bladder cancer.
Wu S; Nitschke K; Worst TS; Fierek A; Weis CA; Eckstein M; Porubsky S; Kriegmair M; Erben P
J Exp Clin Cancer Res; 2020 Dec; 39(1):288. PubMed ID: 33334367
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of long non-coding RNA TUG1 predicts poor prognosis and promotes cancer cell proliferation and migration in high-grade muscle-invasive bladder cancer.
Iliev R; Kleinova R; Juracek J; Dolezel J; Ozanova Z; Fedorko M; Pacik D; Svoboda M; Stanik M; Slaby O
Tumour Biol; 2016 Oct; 37(10):13385-13390. PubMed ID: 27460088
[TBL] [Abstract][Full Text] [Related]
3. Long non-coding RNAs identify a subset of luminal muscle-invasive bladder cancer patients with favorable prognosis.
de Jong JJ; Liu Y; Robertson AG; Seiler R; Groeneveld CS; van der Heijden MS; Wright JL; Douglas J; Dall'Era M; Crabb SJ; van Rhijn BWG; van Kessel KEM; Davicioni E; Castro MAA; Lotan Y; Zwarthoff EC; Black PC; Boormans JL; Gibb EA
Genome Med; 2019 Oct; 11(1):60. PubMed ID: 31619281
[TBL] [Abstract][Full Text] [Related]
4. High IL-22RA1 gene expression is associated with poor outcome in muscle invasive bladder cancer.
Nitschke K; Worst TS; von Rhade SM; Thaqi B; Neuberger M; Wessels F; Weis CA; Porubsky S; Gaiser T; Kriegmair M; von Hardenberg J; Weidenbusch M; Erben P; Nuhn P
Urol Oncol; 2021 Aug; 39(8):499.e1-499.e8. PubMed ID: 34134925
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA LINC00675 is associated with bladder cancer metastasis and patient survival.
Liu X; Ke J; Gu L; Tang H; Luo X
J Gene Med; 2020 Sep; 22(9):e3210. PubMed ID: 32367602
[TBL] [Abstract][Full Text] [Related]
6. An immune relevant signature for predicting prognoses and immunotherapeutic responses in patients with muscle-invasive bladder cancer (MIBC).
Jiang W; Zhu D; Wang C; Zhu Y
Cancer Med; 2020 Apr; 9(8):2774-2790. PubMed ID: 32096345
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of LncRNA MIR31HG in human bladder cancer.
He A; Chen Z; Mei H; Liu Y
Cancer Biomark; 2016 Jul; 17(2):231-6. PubMed ID: 27434291
[TBL] [Abstract][Full Text] [Related]
8. A Competing Endogenous RNA Network and an 8-lncRNA Prognostic Signature Identify
Shen D; Zhang Y; Zheng Q; Yu S; Xia L; Cheng S; Li G
DNA Cell Biol; 2021 Jan; 40(1):26-35. PubMed ID: 33270518
[TBL] [Abstract][Full Text] [Related]
9. Identification of extracellular vesicle-borne periostin as a feature of muscle-invasive bladder cancer.
Silvers CR; Liu YR; Wu CH; Miyamoto H; Messing EM; Lee YF
Oncotarget; 2016 Apr; 7(17):23335-45. PubMed ID: 26981774
[TBL] [Abstract][Full Text] [Related]
10. A comprehensive molecular characterization of the 8q22.2 region reveals the prognostic relevance of OSR2 mRNA in muscle invasive bladder cancer.
Uysal D; Kowalewski KF; Kriegmair MC; Wirtz R; Popovic ZV; Erben P
PLoS One; 2021; 16(3):e0248342. PubMed ID: 33711044
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA CASC9 promotes tumor growth and metastasis via modulating FZD6/Wnt/β-catenin signaling pathway in bladder cancer.
Zhan Y; Zhang L; Yu S; Wen J; Liu Y; Zhang X
J Exp Clin Cancer Res; 2020 Jul; 39(1):136. PubMed ID: 32677984
[TBL] [Abstract][Full Text] [Related]
12. Long non-coding RNA ARAP1-AS1 promotes the progression of bladder cancer by regulating miR-4735-3p/NOTCH2 axis.
Teng J; Ai X; Jia Z; Wang K; Guan Y; Guo Y
Cancer Biol Ther; 2019; 20(4):552-561. PubMed ID: 30404578
[TBL] [Abstract][Full Text] [Related]
13. Subtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer.
Rinaldetti S; Worst TS; Rempel E; Kriegmair MC; Hartmann A; Porubsky S; Bolenz C; Erben P
Sci Rep; 2020 Nov; 10(1):20472. PubMed ID: 33235218
[TBL] [Abstract][Full Text] [Related]
14. LncRNA MIR31HG overexpression serves as poor prognostic biomarker and promotes cells proliferation in lung adenocarcinoma.
Qin J; Ning H; Zhou Y; Hu Y; Yang L; Huang R
Biomed Pharmacother; 2018 Mar; 99():363-368. PubMed ID: 29367106
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.
Yan S; Tang Z; Chen K; Liu Y; Yu G; Chen Q; Dang H; Chen F; Ling J; Zhu L; Huang A; Tang H
J Exp Clin Cancer Res; 2018 Sep; 37(1):214. PubMed ID: 30176933
[TBL] [Abstract][Full Text] [Related]
16. Identification of long non-coding RNAs that stimulate cell survival in bladder cancer.
Dudek AM; Boer SJ; Boon N; Witjes JA; Kiemeney LALM; Verhaegh GW
Oncotarget; 2017 May; 8(21):34442-34452. PubMed ID: 28415801
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA expression profiles in muscle-invasive bladder cancer: identification of a four-microRNA signature associated with patient survival.
Xu Z; Yu YQ; Ge YZ; Zhu JG; Zhu M; Zhao YC; Xu LW; Yang XB; Geng LG; Dou QL; Jia RP
Tumour Biol; 2015 Sep; 36(10):8159-66. PubMed ID: 25990459
[TBL] [Abstract][Full Text] [Related]
18. Unraveling UCA1 lncRNA prognostic utility in urothelial bladder cancer.
Avgeris M; Tsilimantou A; Levis PK; Rampias T; Papadimitriou MA; Panoutsopoulou K; Stravodimos K; Scorilas A
Carcinogenesis; 2019 Aug; 40(8):965-974. PubMed ID: 30815670
[TBL] [Abstract][Full Text] [Related]
19. Serum LUCAT1 implicates the pathogenesis of muscle-invasive bladder cancer via targeting miR-199a-5p and miR-199b-5p.
Zhou Y; Song X; Li X; Li H; Peng Y
J Mol Histol; 2020 Oct; 51(5):583-591. PubMed ID: 32844284
[TBL] [Abstract][Full Text] [Related]
20. Long noncoding RNAs to predict postoperative recurrence in bladder cancer and to develop a new molecular classification system.
Li Z; Jiang L; Zhang Z; Deng M; Wei W; Tang H; Guo S; Ye Y; Yao K; Liu Z; Zhou F
Cancer Med; 2022 Jan; 11(2):539-552. PubMed ID: 34816620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
